Am Heart J

1. RAO VN, Sharma A, Stebbins A, Buse JB, et al
   Regional variation in cause of death in patients with type 2 diabetes: insights from EXSCEL: Cause of Death in Type 2 Diabetes.
   Am Heart J. 2024 Feb 21:S0002-8703(24)00040-1. doi: 10.1016/j.ahj.2024.
   

   >> Share

   
   

   
   Am J Clin Nutr

2. NOERMAN S, Johansson A, Shi L, Lehtonen M, et al
   Fasting plasma metabolites reflecting meat consumption and their associations with incident type 2 diabetes in two Swedish cohorts.
   Am J Clin Nutr. 2024 Feb 23:S0002-9165(24)00157.
   

   >> Share

   
   

   
   Am J Med

3. ZUNIGA-HERNANDEZ JA, Gamboa-Meza A, Medina-Ramirez HA, Nanez-Terreros H, et al
   Pulmonary Coccidioidomycosis Presenting as Recurrent Diabetic Ketoacidosis.
   Am J Med. 2024 Feb 22:S0002-9343(24)00095-0. doi: 10.1016/j.amjmed.2024.
   

   >> Share

   
   
4. KRITTANAWONG C, Escobar J, Virk HUH, Alam M, et al
   Lifestyle Approach and Medical Therapy of Lower Extremity Peripheral Artery Disease.
   Am J Med. 2024;137:202-209.
   

   >> Share

   
   

   
   Am J Nephrol

5. STAVAS J, Silva AL, Wooldridge TD, Aqeel A, et al
   Rilparencel (Renal Autologous Cell Therapy-REACT(R)) for Chronic Kidney Disease and Type 1 and 2 Diabetes: Phase 2 Trial Design Evaluating Bilateral Kidney Dosing and Re-Dosing Triggers.
   Am J Nephrol. 2024 Feb 29. doi: 10.1159/000537942.
   

   >> Share

   
   

   
   BMC Ophthalmol

6. DA SILVA MO, do Carmo Chaves AEC, Gobbato GC, Lavinsky F, et al
   Early choroidal and retinal changes detected by swept-source oct in type 2 diabetes and their association with diabetic kidney disease: a longitudinal prospective study.
   BMC Ophthalmol. 2024;24:85.
   

   >> Share

   
   

   
   BMC Pediatr

7. ZHAO S, Jiang H, Miao Y, Liu W, et al
   Factors influencing necrotizing enterocolitis in premature infants in China: a systematic review and meta-analysis.
   BMC Pediatr. 2024;24:148.
   

   >> Share

   
   

   
   BMJ

8. LANE MM, Gamage E, Du S, Ashtree DN, et al
   Ultra-processed food exposure and adverse health outcomes: umbrella review of epidemiological meta-analyses.
   BMJ. 2024;384:e077310.
   

   >> Share

   
   

   
   Diabetes

9. LI D, Hsu FC, Palmer ND, Liu L, et al
   Multi-omics Analyses Identify AKR1A1 as a Biomarker for Diabetic Kidney Disease.
   Diabetes. 2024 Feb 23:db230540. doi: 10.2337/db23-0540.
   

   >> Share

   
   
10. HAN X, Wei J, Zheng R, Tu Y, et al
    Macrophage SHP2 Deficiency Alleviates Diabetic Nephropathy via Suppression of MAPK/NF-kB-Dependent Inflammation.
    Diabetes. 2024 Feb 23:db230700. doi: 10.2337/db23-0700.
    

    >> Share

    
    

    
    Diabetes Care

11. THOMAS RL, Boeder SC, Hamidi V, Giovannetti ER, et al
    Continuous Glucose Monitoring Time Below Range Predicts Impaired Epinephrine Response to Hypoglycemia in Patients With Type 1 Diabetes.
    Diabetes Care. 2024 Feb 23:dc232501. doi: 10.2337/dc23-2501.
    

    >> Share

    
    
12. WANG S, Gu L, Wang L
    Comment on Li et al. Association of Serum Uric Acid With All-Cause and Cardiovascular Mortality in Diabetes. Diabetes Care 2023;46:425-433.
    Diabetes Care. 2024;47:e31.
    

    >> Share

    
    
13. MURPHY HR
    A Diabetes Pregnancy Technology Roadmap: The 2023 Norbert Freinkel Award Lecture.
    Diabetes Care. 2024;47:324-330.
    

    >> Share

    
    
14. HENSON J, Covenant A, Hall AP, Herring L, et al
    Waking Up to the Importance of Sleep in Type 2 Diabetes Management: A Narrative Review.
    Diabetes Care. 2024;47:331-343.
    

    >> Share

    
    
15. NARAYAN KMV, Kondal D, Chang HH, Mohan D, et al
    Natural History of Type 2 Diabetes in Indians: Time to Progression.
    Diabetes Care. 2024 Mar 1:dc231514. doi: 10.2337/dc23-1514.
    

    >> Share

    
    
16. SIMMONS D, Immanuel J, Hague WM, Teede H, et al
    Perinatal Outcomes in Early and Late Gestational Diabetes Mellitus After Treatment From 24-28 Weeks' Gestation: A TOBOGM Secondary Analysis.
    Diabetes Care. 2024 Feb 29:dc231667. doi: 10.2337/dc23-1667.
    

    >> Share

    
    
17. GONZALEZ JS, Bebu I, Krause-Steinrauf H, Hoogendoorn CJ, et al
    Differential Effects of Type 2 Diabetes Treatment Regimens on Diabetes Distress and Depressive Symptoms in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE): A Randomized Clinical Trial.
    Diabetes Care. 2024 Feb 28:dc232459. doi: 10.2337/dc23-2459.
    

    >> Share

    
    
18. TOZZO V, Genco M, Omololu SO, Mow C, et al
    Estimating Glycemia From HbA1c and CGM: Analysis of Accuracy and Sources of Discrepancy.
    Diabetes Care. 2024;47:460-466.
    

    >> Share

    
    
19. MITCHELL LM, Huang ES
    Diffusion and Disparities: Rural Uptake of Continuous Glucose Monitors.
    Diabetes Care. 2024;47:344-345.
    

    >> Share

    
    
20. SATTAR N, Presslie C, Rutter MK, McGuire DK, et al
    Cardiovascular and Kidney Risks in Individuals With Type 2 Diabetes: Contemporary Understanding With Greater Emphasis on Excess Adiposity.
    Diabetes Care. 2024 Feb 27:dci230041. doi: 10.2337/dci23-0041.
    

    >> Share

    
    
21. SHERR JL, Bergford S, Gal RL, Clements MA, et al
    Exploring Factors That Influence Postexercise Glycemia in Youth With Type 1 Diabetes in the Real World: The Type 1 Diabetes Exercise Initiative Pediatric Study (T1DEXIP).
    Diabetes Care. 2024 Feb 27:dc232212. doi: 10.2337/dc23-2212.
    

    >> Share

    
    

    
    Diabetes Obes Metab

22. LIM S, Lee SH, Min KW, Lee CB, et al
    A multicentre, double-blind, placebo-controlled, randomized, parallel comparison, phase 3 trial to evaluate the efficacy and safety of pioglitazone add-on therapy in type 2 diabetic patients treated with metformin and dapagliflozin.
    Diabetes Obes Metab. 2024 Feb 29. doi: 10.1111/dom.15526.
    

    >> Share

    
    
23. VARGAS KG, Rutten T, Siemes B, Brockmeyer M, et al
    Assessing the potential for precision medicine in body weight reduction with regard to type 2 diabetes mellitus therapies: A meta-regression analysis of 120 randomized controlled trials.
    Diabetes Obes Metab. 2024 Feb 29. doi: 10.1111/dom.15519.
    

    >> Share

    
    
24. WILLIG MR, Stinson EJ, Looker HC, Piaggi P, et al
    Insulin resistance before type 2 diabetes onset is associated with increased risk of albuminuria after diabetes onset: A prospective cohort study.
    Diabetes Obes Metab. 2024 Feb 28. doi: 10.1111/dom.15505.
    

    >> Share

    
    
25. SWIFT C, Frazer M, Gronroos NN, Sargent A, et al
    Real-world glycated haemoglobin changes among type 2 diabetes mellitus patients treated with a maintenance dose of 7 mg or 14 mg of oral semaglutide.
    Diabetes Obes Metab. 2024 Feb 28. doi: 10.1111/dom.15516.
    

    >> Share

    
    
26. BONNET F, Balkau B, Lambert O, Diawara Y, et al
    The number of nephroprotection targets attained is associated with cardiorenal outcomes and mortality in patients with diabetic kidney disease. The CKD-REIN cohort study.
    Diabetes Obes Metab. 2024 Feb 28. doi: 10.1111/dom.15507.
    

    >> Share

    
    
27. ZHAO Y, Han M, Qie R, Zhang Y, et al
    Associations of body mass index trajectory, waist circumference trajectory, or both with type 2 diabetes mellitus risk in Chinese adults: The China-PAR project.
    Diabetes Obes Metab. 2024 Feb 28. doi: 10.1111/dom.15508.
    

    >> Share

    
    
28. IIJIMA H, Gouda M, Hida H, Mori-Anai K, et al
    Renal outcomes with sodium-glucose cotransporter 2 inhibitors in Japanese people with grade 3 chronic kidney disease and type 2 diabetes: Analysis of medical administrative databases.
    Diabetes Obes Metab. 2024 Feb 27. doi: 10.1111/dom.15461.
    

    >> Share

    
    
29. KUNUTSOR SK, Balasubramanian VG, Zaccardi F, Gillies CL, et al
    Glycaemic control and macrovascular and microvascular outcomes: A systematic review and meta-analysis of trials investigating intensive glucose-lowering strategies in people with type 2 diabetes.
    Diabetes Obes Metab. 2024 Feb 26. doi: 10.1111/dom.15511.
    

    >> Share

    
    
30. SHAO X, Lu J, Tao R, Wu L, et al
    Clinically relevant stratification of patients with type 2 diabetes by using continuous glucose monitoring data.
    Diabetes Obes Metab. 2024 Feb 26. doi: 10.1111/dom.15512.
    

    >> Share

    
    
31. SHEN W, Cai L, Wang B, Li J, et al
    Associations of a proinflammatory diet, habitual salt intake, and the onset of type 2 diabetes: A prospective cohort study from the UK Biobank.
    Diabetes Obes Metab. 2024 Feb 26. doi: 10.1111/dom.15517.
    

    >> Share

    
    

    
    Diabetologia

32. LIU B, Xie D, Huang X, Jin S, et al
    Skeletal muscle TET3 promotes insulin resistance through destabilisation of PGC-1alpha.
    Diabetologia. 2024;67:724-737.
    

    >> Share

    
    
33. SANCHEZ-HERNANDEZ RM, Wagner AM
    Should children with type 1 diabetes really receive statin treatment using the same criteria as for children with familial hypercholesterolaemia?
    Diabetologia. 2024 Feb 26. doi: 10.1007/s00125-024-06115.
    

    >> Share

    
    
34. LEHNER CT, Eberl M, Donnachie E, Tanaka LF, et al
    Incidence trend of type 2 diabetes from 2012 to 2021 in Germany: an analysis of health claims data of 11 million statutorily insured people.
    Diabetologia. 2024 Feb 26. doi: 10.1007/s00125-024-06113.
    

    >> Share

    
    
35. COOMANS DE BRACHENE A, Alvelos MI, Szymczak F, Zimath PL, et al
    Interferons are key cytokines acting on pancreatic islets in type 1 diabetes.
    Diabetologia. 2024 Feb 26. doi: 10.1007/s00125-024-06106.
    

    >> Share

    
    
36. TER BRAAKE JG, Fleetwood KJ, Vos RC, Blackbourn L, et al
    Cardiovascular risk management among individuals with type 2 diabetes and severe mental illness: a cohort study.
    Diabetologia. 2024 Feb 26. doi: 10.1007/s00125-024-06111.
    

    >> Share

    
    
37. REUTRAKUL S, Park JC, McAnany JJ, Chau FY, et al
    Dysregulated 24 h melatonin secretion associated with intrinsically photosensitive retinal ganglion cell function in diabetic retinopathy: a cross-sectional study.
    Diabetologia. 2024 Feb 27. doi: 10.1007/s00125-024-06118.
    

    >> Share

    
    
38. JIN Q, Lau ESH, Luk AO, Tam CHT, et al
    Circulating metabolomic markers linking diabetic kidney disease and incident cardiovascular disease in type 2 diabetes: analyses from the Hong Kong Diabetes Biobank.
    Diabetologia. 2024 Feb 27. doi: 10.1007/s00125-024-06108.
    

    >> Share

    
    
39. SU M, Hou Y, Cai S, Li W, et al
    Elevated ITGA1 levels in type 2 diabetes: implications for cardiac function impairment.
    Diabetologia. 2024 Feb 27. doi: 10.1007/s00125-024-06109.
    

    >> Share

    
    
40. SHE R, Suvitaival T, Andersen HU, Hommel E, et al
    Metabolic effect of adrenaline infusion in people with type 1 diabetes and healthy individuals.
    Diabetologia. 2024 Mar 1. doi: 10.1007/s00125-024-06116.
    

    >> Share

    
    

    
    J Am Coll Cardiol

41. HANSEN MK, Olesen KKW, Gyldenkerne C, Thrane PG, et al
    Eligibility for and Preventive Potential of Semaglutide in Overweight and Obese Patients With Myocardial Infarction.
    J Am Coll Cardiol. 2024;83:956-958.
    

    >> Share

    
    
42. OHSHIRO Y
    Rethinking eGFR Comparisons in SGLT2 Inhibitor Research.
    J Am Coll Cardiol. 2024;83:e87.
    

    >> Share

    
    
43. CHATUR S, Vaduganathan M, Claggett B, Solomon SD, et al
    Reply: Rethinking eGFR Comparisons in SGLT2 Inhibitor Research.
    J Am Coll Cardiol. 2024;83:e89.
    

    >> Share

    
    

    
    J Clin Endocrinol Metab

44. TRAMONTANA F, Napoli N, Litwack-Harrison S, Bauer DC, et al
    More rapid bone mineral density loss in older men with diabetes: The Osteoporotic Fractures in Men (MrOS) Study.
    J Clin Endocrinol Metab. 2024 Feb 26:dgae045. doi: 10.1210.
    

    >> Share

    
    
45. RAPINI N, Delvecchio M, Mucciolo M, Ruta R, et al
    The changing landscape of neonatal diabetes mellitus in Italy between 2003-2022.
    J Clin Endocrinol Metab. 2024 Feb 26:dgae095. doi: 10.1210.
    

    >> Share

    
    
46. DRENTHEN LCA, Ajie M, de Baaij JHF, Tack CJ, et al
    Magnesium supplementation modulates T-cell function in people with type 2 diabetes and low serum magnesium levels.
    J Clin Endocrinol Metab. 2024 Feb 27:dgae097. doi: 10.1210.
    

    >> Share

    
    
47. CAI Y, Wei Q, Wang S, Lu X, et al
    All-Cause Mortality Differentials by Diabetes Status and Serum Neurofilament Light Chain Levels in U.S. General Adults.
    J Clin Endocrinol Metab. 2024 Feb 27:dgae102. doi: 10.1210.
    

    >> Share

    
    
48. CHEN GC, Hukportie DN, Liu YJ, Wang HP, et al
    Microvascular Disease, Cardiovascular Health, and Risk of Coronary Heart Disease in Type 2 Diabetes: A UK Biobank Study.
    J Clin Endocrinol Metab. 2024 Feb 27:dgae100. doi: 10.1210.
    

    >> Share

    
    
49. LACLAUSTRA M, Alonso-Ventura V, Schipf S, Lou-Bonafonte JM, et al
    Higher Parametric Thyroid Feedback Quantile-based Index is a predictor of type 2 diabetes in a German population sample.
    J Clin Endocrinol Metab. 2024 Feb 29:dgae110. doi: 10.1210.
    

    >> Share

    
    
50. NIELSEN H, Windolf-Nielsen A, Scheuer SH, Damm P, et al
    Type 2 diabetes risk after gestational diabetes according to country/region of origin. A nationwide register-based study.
    J Clin Endocrinol Metab. 2024 Mar 1:dgae113. doi: 10.1210.
    

    >> Share

    
    

    
    J Diabetes Complications

51. MATSUURA S, Nagata S, Shibazaki K, Uchida R, et al
    Increased skeletal muscle mass index was involved in glycemic efficacy following diabetes treatment, and changes in fat mass index correlated with the changes in the lipid ratio in type 2 diabetes.
    J Diabetes Complications. 2024;38:108717.
    

    >> Share

    
    

    
    J Hypertens

52. TARKKONEN A, Fickweiler W, Eriksson M, Sun JK, et al
    Retinal artery to vein ratio is associated with cerebral microbleeds in individuals with type 1 diabetes.
    J Hypertens. 2024 Feb 28. doi: 10.1097/HJH.0000000000003690.
    

    >> Share

    
    

    
    J Immunol

53. RACINE JJ, Bachman JF, Zhang JG, Misherghi A, et al
    Murine MHC-Deficient Nonobese Diabetic Mice Carrying Human HLA-DQ8 Develop Severe Myocarditis and Myositis in Response to Anti-PD-1 Immune Checkpoint Inhibitor Cancer Therapy.
    J Immunol. 2024 Mar 1:ji2300841. doi: 10.4049/jimmunol.2300841.
    

    >> Share

    
    
54. COSTANZO A, Clarke D, Holt M, Sharma S, et al
    Repositioning the Early Pathology of Type 1 Diabetes to the Extraislet Vasculature.
    J Immunol. 2024 Mar 1:ji2300769. doi: 10.4049/jimmunol.2300769.
    

    >> Share

    
    

    
    JAMA

55. COURCOULAS AP, Patti ME, Hu B, Arterburn DE, et al
    Long-Term Outcomes of Medical Management vs Bariatric Surgery in Type 2 Diabetes.
    JAMA. 2024;331:654-664.
    

    >> Share

    
    
56. WADDEN TA, Kushner RF, Chao AM
    Bariatric Surgery Produces Long-Term Benefits in Patients With Type 2 Diabetes: Evidence Supporting Its Expanded Use and Coverage.
    JAMA. 2024;331:643-645.
    

    >> Share

    
    

    
    Kidney Int

57. CHEN JJ, Lee TH, Yang HY
    Exploring nontraditional cardiorenal advantages of SGLT-2 inhibitors and GLP-1 receptor agonists.
    Kidney Int. 2024;105:442-444.
    

    >> Share

    
    
58. SHAH CV
    Sodium-glucose cotransporter 2 inhibition, epidermal growth factor, and magnesium homeostasis: is there a link?
    Kidney Int. 2024;105:638-639.
    

    >> Share

    
    
59. NEGRI AL
    Sodium-glucose cotransporter 2 inhibitors in the treatment of refractory hypomagnesemia.
    Kidney Int. 2024;105:638.
    

    >> Share

    
    
60. CHEN J, Wang X, He Q, Yang HC, et al
    Inhibition of transcriptional coactivator YAP Impairs the expression and function of transcription factor WT1 in diabetic podocyte injury.
    Kidney Int. 2024 Feb 27:S0085-2538(24)00160-1. doi: 10.1016/j.kint.2024.
    

    >> Share

    
    

    
    Nat Genet

61. CISSE AH, Freathy RM
    New insights into the genetics of diabetes in pregnancy.
    Nat Genet. 2024 Feb 27. doi: 10.1038/s41588-024-01675.
    

    >> Share

    
    

    
    Obstet Gynecol

62. SAVITSKY LM, Hamilton C, Sterrett M, Olerich K, et al
    Universal Fetal Echocardiography for Pregestational Diabetes Mellitus: A Cost-Effectiveness Analysis.
    Obstet Gynecol. 2024 Feb 29. doi: 10.1097/AOG.0000000000005538.
    

    >> Share

    
    

    
    PLoS One

63. BI Y, Gao Y, Xie Y, Zhou M, et al
    White blood cells and type 2 diabetes: A Mendelian randomization study.
    PLoS One. 2024;19:e0296701.
    

    >> Share

    
    
64. SONG DK, Hong YS, Sung YA, Lee H, et al
    Risk factor control and cardiovascular events in patients with type 2 diabetes mellitus.
    PLoS One. 2024;19:e0299035.
    

    >> Share

    
    
65. GOMEZ-RUIZ RP, Cabello-Hernandez AI, Gomez-Perez FJ, Gomez-Samano MA, et al
    Meal frequency strategies for the management of type 2 diabetes subjects: A systematic review.
    PLoS One. 2024;19:e0298531.
    

    >> Share

    
    
66. ZHAO M, Chandra A, Liu L, Zhang L, et al
    Investigation of the reasons for delayed presentation in proliferative diabetic retinopathy patients.
    PLoS One. 2024;19:e0291280.
    

    >> Share

    
    
67. WACHIRAPHANSAKUL N, Vongchaiudomchoke T, Manosroi W, Nochaiwong S, et al
    Comparative effectiveness of glucagon-like peptide-1 receptor agonists on body composition and anthropometric indices: A protocol for a systematic review and network meta-analysis of randomized controlled trials.
    PLoS One. 2024;19:e0297488.
    

    >> Share

    
    
68. KWAN YH, Yoon S, Tai BC, Tan CS, et al
    Empowering patients with comorbid diabetes and hypertension through a multi-component intervention of mobile app, health coaching and shared decision-making: Protocol for an effectiveness-implementation of randomised controlled trial.
    PLoS One. 2024;19:e0296338.
    

    >> Share

    
    
69. LANDRUM KR, Gaynes BN, Akello H, Malava JK, et al
    The longitudinal association of stressful life events with depression remission among SHARP trial participants with depression and hypertension or diabetes in Malawi.
    PLoS One. 2024;19:e0298546.
    

    >> Share

    
    
70. DEFAR A, Zeleke GT, Berhanu D, Lemango ET, et al
    Health system's availability and readiness of health facilities for chronic non-communicable diseases: Evidence from the Ethiopian national surveys.
    PLoS One. 2024;19:e0297622.
    

    >> Share

    
    
71. HAZARI A, Mishra V, Kumar P, Maiya A, et al
    The accuracy of 10 g monofilament use for clinical screening of diabetes peripheral neuropathy among Indian population.
    PLoS One. 2024;19:e0297110.
    

    >> Share

    
    
72. BERMUDEZ-MILLAN A, Feinn R, Lampert R, Perez-Escamilla R, et al
    Household food insecurity is associated with greater autonomic dysfunction testing score in Latinos with type 2 diabetes.
    PLoS One. 2024;19:e0297681.
    

    >> Share

    
    
73. PATELAKIS E, Schienkiewitz A, Truthmann J, Holl RW, et al
    Distribution and determinants of glycosylated hemoglobin in adolescents - Results from a nationwide population-based survey in Germany.
    PLoS One. 2024;19:e0296962.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

74. TASSOULAS LJ, Rankin JA, Elias MH, Wackett LP, et al
    Dinickel enzyme evolved to metabolize the pharmaceutical metformin and its implications for wastewater and human microbiomes.
    Proc Natl Acad Sci U S A. 2024;121:e2312652121.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share